More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$3.53B
EPS
-12.43
P/E ratio
--
Price to sales
0.81
Dividend yield
--
Beta
0.639533
Previous close
$38.70
Today's open
$38.61
Day's range
$37.82 - $39.08
52 week range
$11.43 - $39.70
show more
CEO
Debbie Osteen
Employees
25000
Headquarters
Franklin, TN
Exchange
Nasdaq Global Select
Shares outstanding
92966685
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
What Makes Acadia Healthcare (ACHC) a Strong Momentum Stock: Buy Now?
Does Acadia Healthcare (ACHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Research • Nov 10, 2026

Acadia Healthcare Company, Inc. (ACHC) Presents at 2026 UBS Global Healthcare Conference Transcript
Acadia Healthcare Company, Inc. ( ACHC ) 2026 UBS Global Healthcare Conference November 9, 2026 11:00 AM EST Company Participants Debra Osteen - CEO & Director David Duckworth - Interim Chief Financial Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division Hello, everyone. Thanks for joining us for our next presentation at the UBS Healthcare Conference.
Seeking Alpha • Nov 9, 2026

Acadia Healthcare Company, Inc. (ACHC) Q3 2026 Earnings Call Transcript
Acadia Healthcare Company, Inc. ( ACHC ) Q3 2026 Earnings Call November 5, 2026 9:00 AM EST Company Participants Jason Plagman - Vice President of Investor Relations Debra Osteen - CEO & Director David Duckworth - Interim Chief Financial Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Brian Tanquilut - Jefferies LLC, Research Division Pito Chickering - Deutsche Bank AG, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Lin Zhang - Guggenheim Securities, LLC, Research Division Andrew Mok - Barclays Bank PLC, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Ryan Langston - TD Cowen, Research Division Joanna Gajuk - BofA Securities, Research Division Presentation Operator Welcome to the Acadia Healthcare Third Quarter 2026 Earnings Call. [Operator Instructions] I will now hand the conference over to Jason Plagman, VP, Investor Relations.
Seeking Alpha • Nov 7, 2026

Acadia Healthcare Company, Inc. (ACHC) Hit a 52 Week High, Can the Run Continue?
Acadia Healthcare (ACHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks Investment Research • Nov 6, 2026

Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?
Here is how Acadia Healthcare (ACHC) and Aclaris Therapeutics (ACRS) have performed compared to their sector so far this year.
Zacks Investment Research • Nov 6, 2026

Acadia Healthcare Q3 Earnings Call Highlights
Acadia Healthcare NASDAQ: ACHC raised its full-year 2026 financial guidance for the third consecutive quarter after reporting third-quarter revenue growth and stronger-than-expected adjusted earnings, executives said on the company's earnings call.
MarketBeat • Nov 5, 2026

Acadia Healthcare Announces Third Quarter 2026 Results and Raises Full Year 2026 Financial Guidance
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Results Revenue totaled $895.3 million, an increase of 5.1% compared with the third quarter of 2025 Same-facility revenue increased 5.2% compared with the third quarter of 2025, as patient days increased 1.1% and revenue per patient day increased 4.0% Net income attributable to Acadia tot.
Business Wire • Nov 4, 2026

Acadia Healthcare (ACHC) Surpasses Q3 Earnings and Revenue Estimates
Acadia Healthcare (ACHC) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.72 per share a year ago.
Zacks Investment Research • Nov 5, 2026

Acadia Healthcare to Participate in November Investor Conferences
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in two investor conferences in November. On Monday, November 9, 2026, the Company will participate in the 2026 UBS Global Healthcare Conference. The Company's presentation will begin at 11:00 a.m. Eastern Time/10:00 a.m. Central Time. On Wednesday, November 18, 2026, the Company will participate in the 2026 Stephens Annual Investment Conference. The Company's presen.
Business Wire • Nov 2, 2026

GRAIL Q3 Earnings Ahead: Galleri Test Adoption to Drive Growth
GRAL's Q3 earnings should have benefited from rising Galleri test adoption, expanding digital health partnerships and growing clinical evidence of cancer detection.
Zacks Investment Research • Oct 29, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Acadia Healthcare Company Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.